This is one of the most important steps to ensure product quality and safety in the pharmaceutical industry. In this context, drug analyses must be carried out with the greatest care. To ensure that these analyses are carried out according to internationally recognized standards, Pharmacopoeia Analyses are used.
What is a Pharmacopoeia?
A pharmacopoeia is an official publication containing standards, test methods, and specifications for determining the purity, quality, efficacy, and safety of drugs. There are various pharmacopoeias recognized in different regions around the world.
The most important international pharmacopoeias:
- EP (European Pharmacopoeia): The European Pharmacopoeia sets the standards applicable in European countries.
- USP (United States Pharmacopeia): The pharmacopoeia standard that regulates the quality of drugs in the USA.
- BP (British Pharmacopoeia): The official pharmacopoeia source for the United Kingdom.
- JP (Japanese Pharmacopoeia): The official pharmacopoeia book of Japan.
These pharmacopoeias define the analysis methods, acceptance criteria, and test procedures for active ingredients, excipients, finished products, and raw materials of drugs.
The importance of pharmacopoeia standards in drug analysis
To assess the quality of a drug, it must be analyzed according to the criteria set out in the pharmacopoeias. In particular, pharmacopoeia analyses have become mandatory for approval procedures and routine quality controls.
Most important tests carried out within the pharmacopoeia
- Chemical purity tests
- Determination of the active ingredient
- Identity tests
- Solubility and dispersion tests
- Microbiological controls
- Particle size and appearance analyses
- pH value, viscosity and other physico-chemical parameters
Pharmacopoeia conformity in international trade
In global drug trade, pharmacopoeia conformity is of great importance. For example, companies that export drugs to Europe must comply with EP standards, while USP standards apply to the US market. Therefore, it is a great advantage for manufacturing companies to work with laboratories familiar with various pharmacopoeias.
For whom is this mandatory?
- Drug manufacturers
- Drug importers and exporters
- Research and development companies
- All parties involved in the approval process
- Suppliers of finished products and raw materials
An indispensable step for quality and safety
Tests according to pharmacopoeia standards such as EP, USP, BP and JP in drug analyses are a fundamental guarantee for product reliability, legal compliance and public health. The comprehensive pharmacopoeia analysis services of Nanolab, one of the leading laboratories in this field, are important for the smooth marketing of the product and the assurance of consumer confidence.